Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

GNPX vs ABTS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GNPX Wins Head-to-Head Institutional Verdict (3–3 across 6 Pillars · 5–2 Matrix Metrics)

GNPX Overall Winner 6-Pillar Tally: GNPX 3 – 3 ABTS Matrix Metrics: GNPX 5 – 2 ABTS

As of Nov 20, 2026, Genprex, Inc. (GNPX) is the stronger overall head-to-head candidate over Abits Group Inc (ABTS) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Options & Positioning). GNPX carries a Unified Composite Score of 42.2/100 (HOLD) at $1.45 (N/M Forward P/E, 0.0% operating margin), whereas ABTS carries 46.8/100 (HOLD) at $0.17 (N/M Forward P/E, -46.3% operating margin).

  • Composite vs. Pillar Nuance: While ABTS currently prints a higher short-term Unified Composite Score (46.8/100 HOLD vs. GNPX 42.2/100 HOLD), GNPX captures the overall institutional head-to-head verdict (5–2 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (0.0% vs. -46.3% operating margin) and revenue trajectory (+0.0% vs. -20.0% YoY).
  • Technical & Structure Timing Caution: GNPX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.6); meanwhile ABTS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 13.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About GNPX vs ABTS
GNPX NASDAQ Head-to-Head Winner
Genprex, Inc. Common Stock
Pharmaceutical Preparations
$1.45
-13.17% 1D
Market Cap $2.2M
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -4.68β · 96% Vol
Unified Composite Score
42.2 / 100 HOLD
Tech 25.0 Fund 47.0 Flow 50.0 Mom 59.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -22.2%), weak momentum, RSI 27
RSI-14: 26.6 · SMA20: $2.00 · SMA50: $2.48
ABTS NASDAQ
Abits Group Inc Ordinary Shares
Finance Services
$0.17
-31.92% 1D
Market Cap $906,381
TTM Revenue $8.3M
Forward P/E N/M
Beta / 30D Vol 2.31β · 233% Vol
Unified Composite Score
46.8 / 100 HOLD
Tech 45.0 Fund 47.0 Flow 50.0 Mom 44.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -24.2%), weak momentum, RSI 14
RSI-14: 13.5 · SMA20: $0.59 · SMA50: $0.98

6-Pillar Scorecard Institutional Category Breakdown (GNPX 3 – 3 ABTS)

Columns: Metric · GNPX · ABTS
1. Valuation Multiples ABTS
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M 0.3x
2. Growth & Scale GNPX
Revenue Growth (YoY) +0.0% -20.0%
Earnings Growth (YoY) +0.0% +0.0%
TTM Revenue (USD) N/A $8.3M
Market Cap $2.2M $906,381
3. Profitability & Quality GNPX
Gross Margin N/A 23.7%
Operating Margin 0.0% -46.3%
Net Profit Margin 0.0% -60.8%
Return on Equity (ROE) -233.7% -60.0%
4. Balance Sheet & Cash Flow ABTS
Cash Generation (TTM) N/A $73,322 EBITDA
Cash Flow Margin N/A 0.9% EBITDA Mgn
Net Cash / Leverage $11.26 Book/Sh · -233.7% ROE $1.8M Net Debt (0.24x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning GNPX
Options Structure Phase UNCLASSIFIED BREAKDOWN
Current IV / %ile N/A (N/A) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Markdown DISTRIBUTION · Markdown
6. R&D & Supply-Chain Moat ABTS
OpEx & R&D Intensity N/A 70.0% of Rev ($5.8M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Biotechnology Operator Capital Markets Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: GNPX (5) vs ABTS (2)
Institutional Metric GNPX ABTS Criterion Row Edge
Market Capitalization
Scale
$2.2M $906,381 Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
+0.0% -20.0% Higher Growth GNPX
Operating Margin (TTM)
Profitability
0.0% -46.3% Higher Margin GNPX
Net Profit Margin
Profitability
0.0% -60.8% Higher Margin GNPX
Return on Equity (ROE)
Capital Efficiency
-233.7% -60.0% Higher ROE ABTS
52-Week Range Position
Momentum
11% ($0–$10) 0% ($0–$7) Stronger Trend GNPX
Beta / 30D Volatility
Risk Regime
-4.68β · 96% Vol 2.31β · 233% Vol Lower Realized Risk GNPX
Unified Institutional Score
Composite Signal
42.2 / 100 (HOLD) 46.8 / 100 (HOLD) Higher Composite ABTS
Trailing 12M Revenue (USD)
Operating Scale
N/A $8.3M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 23.7% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · 0.3x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A ($11.26 Book/Sh · -233.7% ROE) $73,322 EBITDA ($1.8M Net Debt (0.24x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GNPX +58.52 pp
GNPX: -26.77% · ABTS: -85.29%
3M Horizon GNPX +22.61 pp
GNPX: -63.93% · ABTS: -86.54%
6M Horizon GNPX +156.4 pp
GNPX: +76.59% · ABTS: -79.81%
1Y Horizon GNPX +40.5 pp
GNPX: -56.59% · ABTS: -97.09%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on GNPX vs ABTS. Trailing 12-month operating profitability (GNPX 0.0% vs ABTS -46.3%) and valuation multiples (GNPX N/M vs ABTS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

GNPX ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. Margin0.0%
ROE / Fwd P/E-233.7% · N/M
ABTS ADR TTM Benchmark FX-Normalized USD
TTM Revenue$8.3M
Gross Margin23.7%
Op. Margin-46.3%
ROE / Fwd P/E-60.0% · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
GNPX UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact GNPX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
ABTS BREAKDOWN
118d in phase · OBV DISTRIBUTION
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact ABTS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
GNPX Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $2.2M market capitalization and 0.0% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
ABTS Moat Profile Cyclical / Execution-Driven Positioning
Capital Markets Operator
Competes within the Capital Markets value chain with $906,381 market capitalization and -46.3% operating margin.
OpEx & R&D Reinvestment 70.0% of Rev ($5.8M)
90D Engineering Disclosures 0 Published

Investor FAQ GNPX vs ABTS Key Questions & Quantitative Answers

As of Nov 20, 2026, Genprex, Inc. (GNPX) is the stronger overall head-to-head candidate over Abits Group Inc (ABTS) in the Tradestie Institutional Equity Comparison Engine, winning 5–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Options & Positioning). GNPX carries a Unified Composite Score of 42.2/100 (HOLD) at $1.45 (N/M Forward P/E, 0.0% operating margin), whereas ABTS carries 46.8/100 (HOLD) at $0.17 (N/M Forward P/E, -46.3% operating margin). Composite vs. Pillar Nuance: While ABTS currently prints a higher short-term Unified Composite Score (46.8/100 HOLD vs. GNPX 42.2/100 HOLD), GNPX captures the overall institutional head-to-head verdict (5–2 matrix metrics and 3–3 across the 6 pillars) due to superior fundamental profitability (0.0% vs. -46.3% operating margin) and revenue trajectory (+0.0% vs. -20.0% YoY). Technical & Structure Timing Caution: GNPX is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 26.6); meanwhile ABTS is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 13.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

GNPX leads the Growth & Scale pillar: GNPX posts +0.0% YoY revenue growth and +0.0% YoY earnings growth on N/A TTM revenue (N/A gross margin, 0.0% operating margin), compared with ABTS at -20.0% YoY revenue growth and +0.0% YoY earnings growth on $8.3M TTM revenue (23.7% gross margin, -46.3% operating margin). On trailing 12-month operating scale, GNPX generates N/A in USD-normalized revenue versus $8.3M for ABTS. In operating R&D and SG&A reinvestment, GNPX deploys N/A (0 90-day corporate R&D disclosures) versus 70.0% of Rev ($5.8M) (0 disclosures) for ABTS.

ABTS screens cheaper on headline valuation multiples. GNPX trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas ABTS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.3x EV/Revenue (0.9% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against GNPX (-233.7% ROE) versus ABTS (-60.0% ROE) capital efficiency.

In options market volatility and institutional positioning, GNPX carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-4.68β · 96% Vol realized risk). By comparison, ABTS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.31β · 233% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.